GC Biopharma/Novel Pharma’s Sanfilippo Syndrome Remedy Obtains FDA IND Approval By Investing.com
YONGIN, South Korea, Could 20, 2024 /PRNewswire/ -- GC Biopharma (006280. KS)…
By
admin
YONGIN, South Korea, Could 20, 2024 /PRNewswire/ -- GC Biopharma (006280. KS)…
Sign in to your account